雷达财经讯，近日，湖北多家精神病医院被曝虚构诊疗项目、套取医保资金，引发广泛关注。据报道，涉事医院包括襄阳融诚医院、襄阳宏安医院、襄阳恒 泰康医院、宜昌夷陵康宁精神病医院等。其中，襄阳恒泰康医院在股权穿透后，实际控制人为A股上市公司爱尔眼科实际控制人陈邦。 天眼查工商信息显示，襄阳恒泰康医院有限公司成立于2019年1月，法定代表人为杨庆伟，注册资本500万人民币，经营范围为精神科、预防保健科、医学检 验科、医学影像科。股东信息显示，该公司由湖南恒泰康康复医疗产业发展有限公司全资持股。值得注意的是，爱尔眼科创始人陈邦为该公司实际控制人。 变更记录显示，去年7月，该公司曾变更财务负责人。 | | 草公司 都在用的商业童询工具 | 童老板 童关系 查风险 | | | | | | --- | --- | --- | --- | --- | --- | --- | | | 宋中小企业发展子基金旗下机构 | 襄阳恒泰康医院有限公司 8 | 天眼一下 ■ 应用 ▼ | | 商务合作 企业级产品、 窗 开通 | | | 基本信息 20 | 法律诉讼 1 | 经营风险 经营信息 52 | 公司发展 | 知识产权 1 | | | ...

（来源：市场星报） 2月2日，全国企业破产重整案件信息网发布合肥市中级人民法院民事裁定书，正式宣告合肥丹凤朝阳妇 产医院有限公司（下称合肥丹凤朝阳妇产医院）破产。从2024年申请停业，到2025年进入破产清算程 序，这家成立多年的民营妇产专科医院就此正式退出医疗市场。 经营不善申请停业 法院受理清算申请 2024年3月27日，合肥市卫生健康委员会发布的《医疗机构停业公示》显示，合肥丹凤朝阳妇产医院因 经营不善，申请停止一切执业活动。经研究，同意其自2024年3月27日至2025年3月27日停业，公示期内 相关单位和个人可提出意见建议。 另据合肥市医疗保障局2024年2月27日发布的公示显示，该院医保定点资质已被纳入注销流程。 2025年7月9日，合肥市中级人民法院作出（2025）皖01破申241号民事裁定书，正式裁定受理合肥丹凤 朝阳妇产医院破产清算案件，标志着该院正式进入破产司法程序。7月17日，法院指定安徽神州行律师 事务所作为该院管理人，负责破产清算相关工作。 随着管理人的调查，合肥丹凤朝阳妇产医院的经营状况被揭开。工商信息显示，该院成立于2012年2 月，注册资本200万元人民币，股东为柯向前、苏纪东 ...

Core Viewpoint - The company Sanbo Brain Science (301293.SZ) is relocating its hospital to a new site, with operations commencing on January 26 at 8:00 AM [1] Company Overview - Sanbo Brain Science was founded by experts in neurology and medical management, including renowned figures such as Luan Guoming, Yu Chunjiang, Shi Xiangen, and Zhang Yang [1] - The company has developed into a specialized chain group focusing on neurological diseases over more than 20 years, establishing itself as a leader in the neurology specialty field in China [1]

Core Viewpoint - Lianchi Hospital is a specialized medical group focusing on "safety, efficacy, and experience," responding to the "Healthy China" national strategy, and emphasizing a patient-centered management model [1] Group 1: Company Overview - Lianchi Hospital operates five hospitals and one elderly care institution, with a total building area of approximately 117,900 square meters and 786 registered beds [1] - The professional team consists of 341 licensed physicians and assistant physicians [1] Group 2: Fundraising and Financial Performance - The funds raised will be used for upgrading existing hospital services, expanding through mergers and acquisitions, establishing a research center, and supplementing working capital [2] - In 2024, the company achieved a revenue of 418 million yuan, a year-on-year increase of 17.39%, and a net profit of 67.59 million yuan, up 19.14% [2] - From January 1 to September 30, 2025, the company reported a revenue of 359 million yuan, a 20.34% increase, and a net profit of 55.51 million yuan, up 17.68% [2] Group 3: Asset Changes - As of September 2025, long-term equity investments decreased by 100%, reducing their proportion of total assets by 14.28 percentage points [5] - Goodwill increased by 233.18%, raising its proportion of total assets by 12.43 percentage points [5] - Intangible assets rose by 1004.57%, increasing their share of total assets by 6.88 percentage points [5] Group 4: Liability Changes - Other payables increased by 106.87%, raising their proportion of total assets by 7.36 percentage points [8] - Short-term borrowings accounted for 4.5% of total assets, which was previously 0 [8] - Deferred tax liabilities surged by 3864.08%, increasing their share of total assets by 1.04 percentage points [8]

Core Viewpoint - Lianchi Hospital Group Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with China Galaxy International as the sole sponsor [1] Group 1: Company Overview - Lianchi Hospital is a boutique specialty medical group with Chinese characteristics, operating 5 hospitals and 1 elderly care institution under a group management structure by September 30, 2025 [1] - The company adheres to a "patient-first" philosophy and implements a "human-centered medical" management model, establishing the well-known "Lianchi Medical" brand [1] Group 2: Unique Medical Services - Lianchi Hospital offers distinctive medical service models, including painless management, enhanced recovery after surgery (ERAS), integrated medical and nursing care, and no-companion nursing [1] - According to Frost & Sullivan data, Lianchi Hospital has become one of the most influential medical groups in China [1]

Core Viewpoint - Lianchi Hospital Group Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with China Galaxy International as its sole sponsor, indicating its intention to expand its operations in the specialized healthcare sector in China [1] Group 1: Company Overview - Lianchi Hospital operates under a group management structure, currently managing five hospitals and one elderly care institution, showcasing its commitment to specialized healthcare services [1] - The company adheres to a "patient-first" core value and implements a "human-centered medical" management model, which emphasizes patient care and innovative medical practices [1] Group 2: Unique Medical Services - Lianchi Hospital has developed a well-known medical brand, "Lianchi Medical," which offers distinctive medical service models including painless management, rapid recovery (ERAS), integrated medical and nursing care, and non-accompanied nursing [1] - According to Frost & Sullivan, Lianchi Hospital has become one of the most influential medical groups in China, highlighting its significant presence in the healthcare industry [1]

Group 1 - The core viewpoint of the article is that Mould Technology (000700.SZ) clarified its business focus, stating that it does not engage in brain-machine related businesses, technologies, or investments [1] - The company operates a cardiovascular tertiary specialty hospital, Mingci Hospital, which is part of its healthcare segment [1] - The interaction on the platform indicates a clear communication from the company regarding its current business operations and future direction [1]

Core Viewpoint - Dongguan Oral Hospital Co., Ltd. has been fined 397,680.23 yuan for violating medical insurance fund regulations from January 2022 to June 2024, marking the first public penalty for the hospital regarding medical insurance violations [1] Company Summary - Dongguan Oral Hospital Co., Ltd. is a private dental specialty hospital established on December 5, 2016, occupying over 20 acres with an initial construction area of over 10,000 square meters [1] - The hospital has been penalized under the Medical Security Fund Usage Supervision and Management Regulations, although it has been clarified that there are no fraudulent claims involved [1] Regulatory Context - The penalty was issued by the medical insurance department based on violations identified during the specified period, highlighting the importance of compliance with medical insurance regulations [1] - The hospital's management declined to comment on the specific reasons for the violations, the diagnostic projects involved, or the subsequent corrective measures [1]

Core Insights - The training sessions organized by Jinan Jiale Reproductive Hospital focused on enhancing clinical skills in the diagnosis and treatment of infertility, specifically addressing "tubal infertility treatment guidelines" and "ultrasound diagnostic techniques for endometriosis" [1][2][3] Group 1: Tubal Infertility Training - Tubal infertility is a major cause of female infertility, requiring high precision in diagnosis and treatment [1] - Dr. Feng Wen provided a systematic overview of the causes, diagnosis, and personalized treatment methods for tubal infertility, emphasizing the importance of accurate assessment for effective treatment [1] - Advanced techniques such as hysterosalpingography and laparoscopic surgery were discussed for their role in locating and assessing the extent of tubal abnormalities [1] Group 2: Endometriosis Ultrasound Diagnosis - Dr. Yang Fuzhen presented on the ultrasound diagnostic standards for endometriosis, a common gynecological condition that can lead to infertility [2] - The presentation included detailed analysis of ultrasound characteristics and differential diagnosis of various types of endometriosis, highlighting the need for a comprehensive evaluation that includes patient history and clinical symptoms [2][3] - Emphasis was placed on the importance of recognizing symptoms such as dysmenorrhea and dyspareunia during ultrasound examinations to improve diagnostic accuracy [3] Group 3: Training Outcomes and Future Directions - The training content was closely aligned with clinical needs, providing practical solutions to common challenges faced by medical staff in infertility diagnosis and treatment [3] - Participants reported significant gains in knowledge and skills, expressing intentions to apply what they learned to enhance service quality [3] - Jinan Jiale Reproductive Hospital is committed to ongoing professional training and improving multidisciplinary collaboration to better serve infertility patients [3]

Core Insights - The bankruptcy of Huangshi Jinxin Maternity Hospital highlights the multiple risks associated with the expansion and management of the Jinxin Group, despite the hospital not being directly under the listed company Jinxin Reproductive [1] Group 1: Hospital Closure and Financial Issues - Huangshi Jinxin Maternity Hospital has completely ceased operations as of October, with visible signs of neglect and financial distress, including a total debt of 22.62 million yuan, of which 3.45 million yuan is owed in employee salaries [2][3] - The hospital's operational challenges are exacerbated by its location away from the main urban area, leading to insufficient customer flow [3] Group 2: Industry Challenges - The declining birth rate in recent years has resulted in a general decrease in patient volume and revenue for maternity hospitals, with Jinxin Reproductive acknowledging the adverse effects of the obstetrics industry's challenges on its performance [3][4] - The financial struggles of Huangshi Jinxin Maternity Hospital reflect broader industry downturns, indicating systemic risks faced by specialized medical groups [7] Group 3: Company Performance and Financial Losses - Jinxin Reproductive reported a revenue of 1.289 billion yuan for the first half of 2025, a year-on-year decline of 10.7%, with a net loss of 1.044 billion yuan, marking a significant downturn from profitability [4] - The company attributed its losses to goodwill impairment, financial asset depreciation, and investment losses, alongside a decline in core business revenue from assisted reproductive services [4] Group 4: Policy Impacts - The inclusion of assisted reproductive services in medical insurance has led to price reductions, which, while potentially increasing patient numbers, directly compresses profit margins [5] Group 5: Structural and Management Risks - Jinxin Medical operates seven medical institutions across various regions, which, while diversifying risk, complicates management and increases brand liability [6] - The interconnectedness of the brand means that operational issues in one facility can adversely affect the overall market confidence in the entire group [6] Conclusion - The bankruptcy of Huangshi Jinxin Maternity Hospital serves as a case study of the systemic risks faced by specialized medical groups amid demographic changes and policy adjustments, emphasizing the need for improved business structure and risk management strategies [7]